Effect of Preoperative Radiological Treatment of Hepatocellular Carcinoma Before Liver Transplantation: A Retrospective Study
Creators
- 1. Section of Radiological Sciences, University of Turin, Via Genova, 3, I-10126 Turin (Italy)
- 2. Department of Gastroenterology, Azienda Ospedaliera San Giovanni, C.so Bramante, I-10126 Turin (Italy)
- 3. Department of Pathology, University of Turin, Via Santena, I-10126 Turin (Italy)
- 4. Liver Transplant Unit, Azienda Ospedaliera San Giovanni, C.so Bramante, I-10126 Turin (Italy)
Description
Purpose: To assess the results of radiological treatment of patients with hepatocellular carcinoma (HCC) performed before orthotopic liver transplantation (OLT). Methods: Sixty-two transplanted patients with a total of 89 HCC nodules were studied; 50 lesions in 38 patients had been treated prior to OLT with transcatheter arterial chemoembolization (TACE; n= 29), percutaneous ethanol injection (PEI; n= 10), or combined therapy (TACE + PEI; n= 11). The induced necrosis was pathologically evaluated. The recurrence rate after OLT in the treated group of patients (n= 38) was compared with that in the non-treated group (n= 24). Results: After TACE, necrosis was complete in 7 of 29 lesions (24.1%), partial in 11 of 29 (37.9%), and absent in 11 of 29 (37.9%). After PEI, necrosis was complete in 8 of 10 lesions (80%), and partial in 2 of 10 (20%). Using combined therapy, necrosis was complete in 11 of 11 lesions (100%). Four of 24 untreated and 4 of 38 treated patients did not survive OLT from causes not related to the HCC; 3 of 20 non-treated patients (15%) and 4 of 34 treated patients (11.8%) had post-OLT recurrence (these last four patients had undergone only TACE and did not have tumor necrosis at pathological examination). Conclusion: TACE of HCC prior to OLT had no influence on the recurrence rate. PEI and combined therapy (TACE + PEI) may be recommended in patients awaiting OLT
Additional details
Identifiers
Publishing Information
- Journal Title
- Cardiovascular and Interventional Radiology
- Journal Volume
- 21
- Journal Issue
- 5
- Journal Page Range
- p. 393-398
- ISSN
- 0174-1551
- CODEN
- CAIRDG
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 39093049
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- COMBINED THERAPY; ETHANOL; HEPATOMAS; INJECTION; LIVER; NECROSIS; PATIENTS
- Descriptors DEC
- ALCOHOLS; BODY; CARCINOMAS; DIGESTIVE SYSTEM; DISEASES; GLANDS; HYDROXY COMPOUNDS; INTAKE; MEDICINE; NEOPLASMS; ORGANIC COMPOUNDS; ORGANS; PATHOLOGICAL CHANGES; THERAPY
Optional Information
- Copyright
- Copyright (c) 1998 Springer-Verlag New York Inc.